Survivin Antigen

Preferred Label : Survivin Antigen;

NCIt definition : A tumor-associated antigen. Vaccination with survivin antigen may result in a cytotoxic T-cell response against survivin antigen-expressing tumor cells, resulting in decreased tumor cell proliferation and tumor cell death. Overexpressed in many tumors, endogenous survivin inhibits tumor cell apoptosis.;

Détails

Origin ID

C37449;

UMLS CUI

C0664336;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Survivin [MeSH Descriptor]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- Baculoviral IAP Repeat-Containing Protein 5 [NCIt concept]
is_component_of_chemotherapy_regimen
- Autologous Dendritic Cells/Keyhole Limpet Hemocyanin/MAGE-3/Melan-A/Survivin Antigen [NCIt concept]
- Autologous Dendritic Cells/MAGE-3/Melan-A/Survivin Antigen [NCIt concept]
is_target
- Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients